What's Going On With Taiwan Semiconductor Stock On Thursday?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 19 2024
0mins
Source: Benzinga
Leadership Change at TSMC: Rose Castanares has been promoted to president of Taiwan Semiconductor Manufacturing Co, taking over from Brian Harrison on October 1, as the company continues to expand its operations in Arizona with significant investments and new chip deals.
Stock Performance and Market Impact: TSMC's stock rose by 3.88% following a U.S. Federal Reserve interest rate cut, and the company has seen a 90% increase in stock value over the past year, bolstered by its role as a key supplier for major tech companies like Nvidia and Apple.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVDA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise
41 Analyst Rating
39 Buy
1 Hold
1 Sell
Strong Buy
Current: 207.410
Low
200.00
Averages
264.97
High
352.00
Current: 207.410
Low
200.00
Averages
264.97
High
352.00
About NVDA
NVIDIA Corporation is an artificial intelligence (AI) infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. Its segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing and networking platforms and AI solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment includes GeForce GPUs for gaming and personal computers (PCs), and Quadro/NVIDIA RTX GPUs for enterprise workstation graphics. Its technology stack includes the foundational NVIDIA CUDA development platform that runs on all NVIDIA GPUs, as well as hundreds of domain-specific software libraries, frameworks, algorithms, software development kits (SDKs), and application programming interfaces (APIs). Its platforms address four markets, which include Data Center, Gaming, Professional Visualization, and Automotive.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nvidia's AI-Driven Growth Surges Significantly
- Stellar Financial Performance: Nvidia achieved a staggering 1,250% revenue increase and a 4,000% net income surge in 2023, driving a 1,320% rise in stock price, showcasing the company's robust performance and market dominance in AI.
- Data Center Growth: The company commands an 85% to 92% share of the data center GPU market, with global spending expected to reach $7 trillion by 2030, further solidifying Nvidia's leadership position in this booming sector.
- Optimistic Future Outlook: CEO Jensen Huang stated that Nvidia has visibility into $500 billion in sales over the next two years, with expectations to exceed $1 trillion in revenue by 2027, indicating strong growth potential ahead.
- Accelerated R&D Cycle: By shortening its GPU update cycle to 12-18 months compared to competitors' 3-5 years, Nvidia enhances its competitive edge in AI, with projections suggesting a market cap of $20 trillion by 2030.
See More
Nvidia Plans to Raise $20 Billion in Debt Market
- Large Financing Plan: Nvidia is planning to raise approximately $20 billion through the debt market, indicating the company's confidence in future growth and potentially supporting its expansion in AI and data center sectors.
- Positive Market Reaction: Nvidia's stock showed stability during afternoon trading on June 15, 2026, suggesting investor approval of the financing plan, which may further drive stock price appreciation.
- Diverse Use of Funds: The proceeds from this financing are expected to be allocated towards R&D, acquisitions, and infrastructure investments, aimed at strengthening the company's position in the competitive semiconductor market and enhancing long-term profitability.
- Strategic Implications: By raising funds, Nvidia can accelerate technological innovation and maintain a competitive edge in a rapidly changing market environment, further solidifying its market share in AI and high-performance computing.
See More
SpaceX IPO: A Path to Millionaire Status?
- Enormous Market Potential: SpaceX's total addressable market (TAM) is estimated at $28.5 trillion, encompassing diverse sectors such as space exploration, broadband connectivity, and artificial intelligence, indicating a strategic diversification that could support long-term compounding if management execution remains strong.
- Impressive IPO Performance: SpaceX completed its IPO on June 12 at $135 per share, marking the largest IPO in history, with the stock soaring on its first trading day and pushing the company's valuation past $2 trillion, generating significant media and retail investor excitement.
- Complex Lock-Up Mechanism: The S-1 filing reveals a tiered lock-up agreement allowing gradual stock sales post-first quarterly earnings report, which may lead to future price volatility; investors should approach this with caution as shares become available.
- Investment Strategy Advice: While SpaceX's scale and potential are enticing, investors are advised to wait post-IPO for the lock-up expirations and monitor company developments to find better entry points that reflect actual fundamentals rather than short-term hype.
See More
Three Stocks Thriving Amid Economic Headwinds
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine, mRNA-1010, aimed at addressing the low effectiveness of current flu vaccines, particularly for the elderly, which could significantly enhance its competitive position in the vaccine market.
- Krystal Biotech Strong Performance: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek, and as it expands into new markets in Europe, its revenue is expected to continue growing, showcasing its strong potential in the biotech sector.
- AMD Market Share Growth: AMD's stock has surged 129% year-to-date, with its desktop CPU market share rising to 33.2% and achieving a record 46.2% revenue share, indicating its strong competitive edge and pricing power in the AI sector.
- AI Market Opportunities: With the rise of agentic AI systems, AMD's EPYC processors are positioned as leaders in the server CPU market, potentially benefiting from a $200 billion market opportunity, further solidifying its industry standing.
See More
Investment Outlook for Moderna, Krystal Biotech, and AMD
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which addresses a critical need for effective vaccines among the elderly, potentially enhancing the company's market position and financial performance significantly.
- Krystal Biotech Growth Potential: Krystal Biotech has achieved 11 consecutive quarters of earnings growth with its gene therapy Vyjuvek for a rare disease, and it still has a large addressable market to explore, with upcoming clinical data likely to further boost its stock price.
- AMD Market Leadership: AMD's stock has soared 129% year-to-date, and its leadership in the server CPU market positions it well to capitalize on the rapidly growing artificial intelligence sector, which is expected to continue driving revenue and market share growth.
- Economic and Market Performance: Despite economic and geopolitical challenges, the S&P 500 has risen 8% so far this year, demonstrating overall market resilience, with standout performances from companies like Moderna, Krystal Biotech, and AMD, making them attractive investment options.
See More
Three Stocks Outperforming the Market
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which could significantly improve health outcomes for elderly patients and meet the urgent market need for effective vaccines, potentially leading to stronger financial performance over the next two years.
- Krystal Biotech Growth Momentum: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek for a rare disease, and it is expected to continue expanding its market presence while launching more clinical trial candidates, driving sustained revenue growth.
- AMD Market Leadership: AMD's stock has surged 129% year-to-date, with its desktop CPU market share reaching 33.2% and a record revenue share of 46.2%, showcasing its strong competitive position in the rapidly growing artificial intelligence sector.
- Optimistic Investment Outlook: Despite significant stock price increases for Moderna, Krystal Biotech, and AMD, they are still viewed as worthwhile investments, with potential for higher returns in the future, particularly against the backdrop of ongoing innovation and market expansion in their respective fields.
See More
Nvidia's AI-Driven Growth Surges Significantly
- Stellar Financial Performance: Nvidia achieved a staggering 1,250% revenue increase and a 4,000% net income surge in 2023, driving a 1,320% rise in stock price, showcasing the company's robust performance and market dominance in AI.
- Data Center Growth: The company commands an 85% to 92% share of the data center GPU market, with global spending expected to reach $7 trillion by 2030, further solidifying Nvidia's leadership position in this booming sector.
- Optimistic Future Outlook: CEO Jensen Huang stated that Nvidia has visibility into $500 billion in sales over the next two years, with expectations to exceed $1 trillion in revenue by 2027, indicating strong growth potential ahead.
- Accelerated R&D Cycle: By shortening its GPU update cycle to 12-18 months compared to competitors' 3-5 years, Nvidia enhances its competitive edge in AI, with projections suggesting a market cap of $20 trillion by 2030.
See More
Nvidia Plans to Raise $20 Billion in Debt Market
- Large Financing Plan: Nvidia is planning to raise approximately $20 billion through the debt market, indicating the company's confidence in future growth and potentially supporting its expansion in AI and data center sectors.
- Positive Market Reaction: Nvidia's stock showed stability during afternoon trading on June 15, 2026, suggesting investor approval of the financing plan, which may further drive stock price appreciation.
- Diverse Use of Funds: The proceeds from this financing are expected to be allocated towards R&D, acquisitions, and infrastructure investments, aimed at strengthening the company's position in the competitive semiconductor market and enhancing long-term profitability.
- Strategic Implications: By raising funds, Nvidia can accelerate technological innovation and maintain a competitive edge in a rapidly changing market environment, further solidifying its market share in AI and high-performance computing.
See More
SpaceX IPO: A Path to Millionaire Status?
- Enormous Market Potential: SpaceX's total addressable market (TAM) is estimated at $28.5 trillion, encompassing diverse sectors such as space exploration, broadband connectivity, and artificial intelligence, indicating a strategic diversification that could support long-term compounding if management execution remains strong.
- Impressive IPO Performance: SpaceX completed its IPO on June 12 at $135 per share, marking the largest IPO in history, with the stock soaring on its first trading day and pushing the company's valuation past $2 trillion, generating significant media and retail investor excitement.
- Complex Lock-Up Mechanism: The S-1 filing reveals a tiered lock-up agreement allowing gradual stock sales post-first quarterly earnings report, which may lead to future price volatility; investors should approach this with caution as shares become available.
- Investment Strategy Advice: While SpaceX's scale and potential are enticing, investors are advised to wait post-IPO for the lock-up expirations and monitor company developments to find better entry points that reflect actual fundamentals rather than short-term hype.
See More
Three Stocks Thriving Amid Economic Headwinds
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine, mRNA-1010, aimed at addressing the low effectiveness of current flu vaccines, particularly for the elderly, which could significantly enhance its competitive position in the vaccine market.
- Krystal Biotech Strong Performance: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek, and as it expands into new markets in Europe, its revenue is expected to continue growing, showcasing its strong potential in the biotech sector.
- AMD Market Share Growth: AMD's stock has surged 129% year-to-date, with its desktop CPU market share rising to 33.2% and achieving a record 46.2% revenue share, indicating its strong competitive edge and pricing power in the AI sector.
- AI Market Opportunities: With the rise of agentic AI systems, AMD's EPYC processors are positioned as leaders in the server CPU market, potentially benefiting from a $200 billion market opportunity, further solidifying its industry standing.
See More
Investment Outlook for Moderna, Krystal Biotech, and AMD
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which addresses a critical need for effective vaccines among the elderly, potentially enhancing the company's market position and financial performance significantly.
- Krystal Biotech Growth Potential: Krystal Biotech has achieved 11 consecutive quarters of earnings growth with its gene therapy Vyjuvek for a rare disease, and it still has a large addressable market to explore, with upcoming clinical data likely to further boost its stock price.
- AMD Market Leadership: AMD's stock has soared 129% year-to-date, and its leadership in the server CPU market positions it well to capitalize on the rapidly growing artificial intelligence sector, which is expected to continue driving revenue and market share growth.
- Economic and Market Performance: Despite economic and geopolitical challenges, the S&P 500 has risen 8% so far this year, demonstrating overall market resilience, with standout performances from companies like Moderna, Krystal Biotech, and AMD, making them attractive investment options.
See More
Three Stocks Outperforming the Market
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which could significantly improve health outcomes for elderly patients and meet the urgent market need for effective vaccines, potentially leading to stronger financial performance over the next two years.
- Krystal Biotech Growth Momentum: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek for a rare disease, and it is expected to continue expanding its market presence while launching more clinical trial candidates, driving sustained revenue growth.
- AMD Market Leadership: AMD's stock has surged 129% year-to-date, with its desktop CPU market share reaching 33.2% and a record revenue share of 46.2%, showcasing its strong competitive position in the rapidly growing artificial intelligence sector.
- Optimistic Investment Outlook: Despite significant stock price increases for Moderna, Krystal Biotech, and AMD, they are still viewed as worthwhile investments, with potential for higher returns in the future, particularly against the backdrop of ongoing innovation and market expansion in their respective fields.
See More
